References
- Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM, Finke JH. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Research. 1993. 53: 1380-1387.
- Balkwill F. Cancer and the chemokine network. Nature Reviews Cancer. 2004. 4: 540-550. https://doi.org/10.1038/nrc1388
- Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005. 80: S254-264. https://doi.org/10.1097/01.tp.0000186382.81130.ba
- Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002. 420: 860-867. https://doi.org/10.1038/nature01322
- Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: From immunosurveillance to tumor escape. Nature Immunology. 2002. 3: 991-998. https://doi.org/10.1038/ni1102-991
- Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews Immunology 2009. 9: 162-174. https://doi.org/10.1038/nri2506
- Heo CK, Bahk YY, Cho EW. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers. BMB Reports. 2012. 45: 677-685. https://doi.org/10.5483/BMBRep.2012.45.12.236
- Kandil A, Bazarbashi S, Mourad WA. The correlation of epsteinbarr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing hodgkin disease. Cancer. 2001. 91: 1957-1963. https://doi.org/10.1002/1097-0142(20010601)91:11<1957::AID-CNCR1220>3.0.CO;2-6
- Kim HS, Kim-Schulze S, Kim DW, Kaufman HL. Host lymphodepletion enhances the therapeutic activity of an oncolytic vaccinia virus expressing 4-1bb ligand. Cancer Research. 2009. 69: 8516-8525. https://doi.org/10.1158/0008-5472.CAN-09-2522
- Klebanoff CA, Gattinoni L, Restifo NP. Cd8+ t-cell memory in tumor immunology and immunotherapy. Immunological Reviews. 2006. 211: 214-224. https://doi.org/10.1111/j.0105-2896.2006.00391.x
- Kulbe H, Levinson NR, Balkwill F, Wilson JL. The chemokine network in cancer--much more than directing cell movement. The International Journal of Developmental Biology 2004. 48: 489-496. https://doi.org/10.1387/ijdb.041814hk
- Moodycliffe AM, Maiti S, Ullrich SE. Splenic nk1.1-negative, tcr alpha beta intermediate cd4+ t cells exist in naive nk1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of il-4 and ifn-gamma upon primary tcr stimulation. Journal of Immunology. 1999. 162: 5156-5163.
- Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct t cell-suppressive activity. Blood. 2008. 111: 4233-4244. https://doi.org/10.1182/blood-2007-07-099226
- Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nature Reviews Cancer. 2008. 8: 618-631. https://doi.org/10.1038/nrc2444
- Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells. Advances in Experimental Medicine and Biology 2007. 601: 213-223. https://doi.org/10.1007/978-0-387-72005-0_22
- Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells in human cancer. Cancer Journal. 2010. 16: 348-353. https://doi.org/10.1097/PPO.0b013e3181eb3358
- Nagaraj S, Schrum AG, Cho HI, Celis E, Gabrilovich DI. Mechanism of t cell tolerance induced by myeloid-derived suppressor cells. Journal of Immunology 2010. 184: 3106-3116. https://doi.org/10.4049/jimmunol.0902661
- Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H. Cd8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Research. 1998. 58: 3491-3494.
- Nomura T, Sakaguchi S. Naturally arising cd25+cd4+ regulatory T cells in tumor immunity. Current Topics in Microbiology and Immunology 2005. 293: 287-302.
- Pellicci DG, Hammond KJ, Coquet J, Kyparissoudis K, Brooks AG, Kedzierska K, Keating R, Turner S, Berzins S, Smyth MJ, Godfrey DI. Dx5/cd49b-positive t cells are not synonymous with cd1d-dependent nkt cells. Journal of Immunology 2005. 175: 4416-4425. https://doi.org/10.4049/jimmunol.175.7.4416
- Sakaguchi S. Naturally arising foxp3-expressing cd25+cd4+ regulatory t cells in immunological tolerance to self and non-self. Nature Immunology 2005. 6: 345-352. https://doi.org/10.1038/ni1178
- Sakaguchi S, Sakaguchi N. Regulatory t cells in immunologic self-tolerance and autoimmune disease. International Reviews of Immunology 2005. 24: 211-226. https://doi.org/10.1080/08830180590934976
- Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory t lymphocytes with distinct homing potentials and effector functions. Nature. 1999. 401: 708-712. https://doi.org/10.1038/44385
- Terabe M, Berzofsky JA. The role of nkt cells in tumor immunity. Advances in Cancer Research. 2008. 101: 277-348. https://doi.org/10.1016/S0065-230X(08)00408-9
- Whiteside TL. Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention. Seminars in Cancer Biology. 2006. 16: 3-15. https://doi.org/10.1016/j.semcancer.2005.07.008
- Willimsky G, Blankenstein T. Sporadic immunogenic tumours avoid destruction by inducing t-cell tolerance. Nature. 2005. 437: 141-146. https://doi.org/10.1038/nature03954
- Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Journal of Leukocyte Biology 2012. 91: 167-181. https://doi.org/10.1189/jlb.0311177
- Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity. European Journal of Immunology 2010. 40: 2969-2975. https://doi.org/10.1002/eji.201040895
- Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX. Intratumor depletion of cd4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. The Journal of Experimental Medicine 2005. 201: 779-791. https://doi.org/10.1084/jem.20041684
- Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Lienard D, Lejeune F, Rimoldi D, Guillaume P, Meidenbauer N, Mackensen A, Rufer N, Lubenow N, Speiser D, Cerottini JC, Romero P, Pittet MJ. Effector function of human tumorspecific cd8 t cells in melanoma lesions: A state of local functional tolerance. Cancer Research. 2004. 64: 2865-2873. https://doi.org/10.1158/0008-5472.CAN-03-3066